Fig. 5From: Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trialsComparison of DFS between adjuvant EGFR-TKIs versus adjuvant chemotherapy/placebo in the subgroupBack to article page